Enanta Pharmaceuticals (ENTA) Cash & Equivalents (2012 - 2026)
Enanta Pharmaceuticals' Cash & Equivalents was $33.42 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 25.4% from $44.81 million a year earlier and down 4.3% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Cash & Equivalents at Enanta Pharmaceuticals came in at $32.3 million, down 13.3% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -18.0% (FY2020 to FY2025).
- In earlier fiscal years, Cash & Equivalents was $37.23 million in FY2024 (-56.4%), $85.39 million in FY2023 (+94.1%), $43.99 million in FY2022 (-23.1%) and $57.21 million in FY2021 (-34.3%).
- Quarterly Cash & Equivalents has moved between $28.37 million (fiscal Q3 2022) and $99.07 million (fiscal Q1 2022) over five years.
- Compared with a year earlier, Cash & Equivalents has declined for four straight quarters, with an average decline of 7.7% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was fiscal Q3 2022 (growth of 516.5%); the worst was fiscal Q3 2024 (a decline of 62.4%).
- Per Business Quant data, ENTA's Cash & Equivalents in the three fiscal quarters before Q3 2026 was $34.93 million (Q2 2026), $37.44 million (Q1 2026) and $32.3 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Enanta Pharmaceuticals | 326.73 Mn | -401.27 Mn | - | 33.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.42 Mn |
| Mar 31, 2026 | 34.93 Mn |
| Dec 31, 2025 | 37.44 Mn |
| Sep 30, 2025 | 32.30 Mn |
| Jun 30, 2025 | 44.81 Mn |
| Mar 31, 2025 | 60.21 Mn |
| Dec 31, 2024 | 84.35 Mn |
| Sep 30, 2024 | 37.23 Mn |
| Jun 30, 2024 | 35.78 Mn |
| Mar 31, 2024 | 63.54 Mn |
| Dec 31, 2023 | 39.93 Mn |
| Sep 30, 2023 | 85.39 Mn |
| Jun 30, 2023 | 95.18 Mn |
| Mar 31, 2023 | 73.18 Mn |
| Dec 31, 2022 | 42.22 Mn |
| Sep 30, 2022 | 43.99 Mn |
| Jun 30, 2022 | 28.37 Mn |
| Mar 31, 2022 | 40.99 Mn |
| Dec 31, 2021 | 99.07 Mn |
| Sep 30, 2021 | 57.21 Mn |
API Access
Enanta Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();